MIBE start-up ORBEM closes Series B financing round worth €55.5 million
Source: https://www.bioengineering.tum.de/en/news/details/mibe-start-up-orbem-closes-series-b-financing-round-worth-eur55-million Parent: https://www.bioengineering.tum.de/en/
The founders of ORBEM, Miguel Molina Romero, Maria Laparidou und Pedro Gómez, together with TUM Vice President Prof. Claudia Peus (from left)\ Image: Andreas Heddergott / TUM
ORBEM, a start-up that emerged from the Munich Institute of Biomedical Engineering (MIBE), has announced the successful completion of a Series B financing round. With the growth capital, the company plans to scale its AI-supported MRI technology, enter the US market, and develop new applications.
Founded in 2019 by two Graduate Center BioEngineering (GCB) alumni from the Munich Institute of Biomedical Engineering, together with a colleague from the field of reproductive biotechnology, Munich-based deep tech company ORBEM has received €55.5 million in a Series B financing round.
This funding will enable ORBEM to continue its international expansion, particularly with regard to entering the US market. The start-up also plans to expand its existing technological solutions and develop new applications for food production and the healthcare sector.
About ORBEM
ORBEM has developed a non-invasive imaging technology for analyzing eggs that can determine the fertilization status and sex of the embryo. This technology is based on AI-supported magnetic resonance imaging (MRI) and is extremely important for the poultry industry. Male embryos can be identified early and reliably without damaging the eggshell, thus avoiding the killing of male chicks. Another ORBEM process enables unfertilized eggs to be identified before incubation, allowing them to be used for other purposes and reducing food waste.
ORBEM has received several awards for its technological innovations, including the TUM IDEAward and third prize in the Munich Business Plan Competition (BayStartUP). The ORBEM team has also participated in EIT Food's Global Food Venture Program. In December 2024, the president of TUM awarded the ORBEM founding team the honorary title of 'TUM Entrepreneurs of Excellence'.
More Information
- Series B financing for ORBEM
- ORBEM’s founders awarded as 'TUM Entrepreneurs of Excellence'
- More about ORBEM
Contact Media Relations
MIBE media relations
presse@bioengineering.tum.de